Malaria & Product Knowledge Center

Plain-language guides based on the WHO Guidelines for Malaria (2026) — written for buyers, distributors and health-program teams.

WHO-based guide

What Is ACT? Artemisinin-Based Combination Therapy Explained

ACT is the WHO-recommended first-line treatment for the most deadly form of malaria. Here is what it is, why two drugs are combined, and which ACTs WHO recommends. Read Guide › WHO-based guide

Artemether-Lumefantrine: Uses, 3-Day Dosing and WHO Guidance

The world's most-used ACT: how artemether-lumefantrine works, the 6-dose 3-day schedule, taking it with fat, and WHO's latest guidance for pregnancy and infants. Read Guide › WHO-based guide

Severe Malaria: Why WHO Recommends Injectable Artesunate First

Untreated severe malaria kills almost 100% of patients. WHO's answer: intravenous or intramuscular artesunate — the single most important drug in malaria emergency care. Read Guide › WHO-based guide

Malaria Treatment for Children: Weight-Based Dosing and Pediatric Formulations

Children carry the heaviest malaria burden. How weight-band dosing works, why suspensions and suppositories exist, and what WHO says about infants under 5 kg. Read Guide › WHO-based guide

Seasonal Malaria Chemoprevention (SMC): Protecting Children Through the Rainy Season

In Africa's Sahel, most malaria hits during a few rainy months. SMC — monthly courses of SP + amodiaquine given to children each transmission season — prevents millions of cases. Read Guide › WHO-based guide

Malaria in Pregnancy: IPTp Prevention and Safe Treatment Explained

Malaria in pregnancy endangers both mother and baby. WHO's two-part answer: preventive SP doses at antenatal visits (IPTp), plus artemether-lumefantrine as safe treatment in every trimester. Read Guide › WHO-based guide

Test Before You Treat: Malaria Diagnosis with RDTs and Microscopy

WHO's rule is simple: confirm every suspected malaria case with a parasitological test before treatment. Here is how RDTs and microscopy compare, and why the rule protects both patients and drug supply. Read Guide › WHO-based guide

Substandard Antimalarials: Why GMP Quality and WHO Prequalification Matter

Falsified and substandard malaria medicines still kill patients and breed resistance. How GMP manufacturing, batch documentation and WHO prequalification protect your program — and what to demand from suppliers. Read Guide ›

✎ 💬 ↑

👋 Hi! I'm Care, your product guide. Tap me to ask about our medicines & APIs. ×

Care - product guide assistant